Evidence map›Paper›PMID 35942683›Full record

ArticleeLife2022

Positive feedback regulation of

Takayoshi Yamamoto, Yuta Kambayashi, Yuta Otsuka, Boni A Afouda, Claudiu Giuraniuc, Tatsuo Michiue, Stefan Hoppler

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Takayoshi YamamotoDepartment of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan.ORCID 0000-0001-8028-6050
Yuta KambayashiDepartment of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan.ORCID 0000-0001-5219-6592
Yuta OtsukaDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0003-3872-4349
Boni A AfoudaInstitute of Medical Sciences, The University of Aberdeen, Aberdeen, United Kingdom.
Claudiu GiuraniucInstitute of Medical Sciences, The University of Aberdeen, Aberdeen, United Kingdom.ORCID 0000-0001-7127-2642
Tatsuo MichiueDepartment of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan.ORCID 0000-0001-9047-0513
Stefan HopplerInstitute of Medical Sciences, The University of Aberdeen, Aberdeen, United Kingdom.ORCID 0000-0003-0730-4798
Tokyo University of the Arts · JPUniversity of Aberdeen · GBThe University of Tokyo · JP

Funding

Biotechnology and Biological Sciences Research Council BB/M001695/1Biotechnology and Biological Sciences Research Council BB/N021924/1British Heart Foundation RG/18/8/33673
6 · The paper itself

Abstract

Secreted molecules called morphogens govern tissue patterning in a concentration-dependent manner. However, it is still unclear how reproducible patterning can be achieved with diffusing molecules, especially when that patterning concerns differentiation of thin tissues. Wnt is a morphogen that organizes cardiac development. Wnt6 patterns cardiogenic mesoderm to induce differentiation of a thin tissue, the pericardium, in

Indexed as

Heparan SulfateWnt Signaling PathwayAnimalsComputer SimulationFeedbackXenopus laevisHeparan Sulfatedevelopmental biologyfrizzledgene regulatory circuitheartmorphogenWnt signalxenopusXenopus

Identifiers

PMID35942683
PMCPMC9363125
OpenAlexW4287921764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.